Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: A randomized controlled pilot study

Drugs in R and D

Volumn 10, Issue 3, 2010, Pages 155-163

  Naritomi, Hiroaki ^a   Moriwaki, Hiroshi ^b   Metoki, Norifumi ^c   Nishimura, Hiroyuki ^d   Higashi, Yasuto ^e   Yamamoto, Yasumasa ^f   Yuasa, Hiroyuki ^g   Oe, Hiroshi ^a   Tanaka, Kortaro ^h   Saito, Kozue ^b   Terayama, Yasuo ⁱ   Oda, Tadafumi ^j   Tanahashi, Norio ^k   Kondo, Hisao ^l  

^a Senri Chuo Hospital   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c Hirosaki Stroke Center   (Japan)

^d NISHINOMIYA KYORITSU NEUROSURGICAL HOSPITAL   (Japan)

^e Himeji Central Hospital   (Japan)

^f KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^g TOSEI GENERAL HOSPITAL   (Japan)

^h UNIVERSITY OF TOYAMA   (Japan)

ⁱ IWATE MEDICAL UNIVERSITY   (Japan)

^j Saito Yukoukai Hospital   (Japan)

^k SAITAMA MEDICAL UNIVERSITY   (Japan)

^l KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

Edaravone, therapeutic use; Muscular atrophy, treatment; Stroke, treatment

Indexed keywords

NORPHENAZONE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; GAIT DISORDER; HUMAN; LIMB WEAKNESS; LOCOMOTION; LONG TERM CARE; MALE; MULTICENTER STUDY; MUSCLE ATROPHY; PARESIS; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WALKING SPEED;

AGED; ANTIPYRINE; BRAIN ISCHEMIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFUSIONS, INTRAVENOUS; LEG; MALE; MUSCULAR ATROPHY; PARESIS; PILOT PROJECTS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; STROKE; WALKING;

EID: 79952534453     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.2165/11586550-000000000-00000     Document Type: Article

References (29)

1. Donnan GA, Fisher M, Macleod M, et al. Stroke. Lancet 2008 May 10; 371(9624):1612-23 (Pubitemid 351626845)
2. Schneider R, Gautier JC. Leg weakness due to stroke: site of lesions, weakness patterns and causes. Brain 1994 Apr; 117 (Pt 2):347-54
3. Kortebein P, Ferrando A, Lombeida J, et al. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007 Apr. 25; 297(16):1772-4 (Pubitemid 46658661)
4. Kondo K, Ota T. Changes with time in cross-sectional areas of leg muscles in early stroke rehabilitation patients: disuse muscle atrophy and its recovery. Jpn J Rehabil Med 1997;34:124-33
5. Odajima N, Ishiai S, Okiyḿ R, et al. CT findings of leg muscles in the hemiplegics due to cerebrovascular accidents: correlation to disuse atrophy. Rinsho Shinkeigaku 1987 Sep; 27(9):1154-62
6. Kondo H. Oxidative stress in skeletal muscle atrophy induced by immobilization. In: Reznick AZ, editor. Oxidative stress in skeletal muscle. Basel: Birkhauser, 1998:197-13
7. Kondo H. Oxidative stress in muscular atrophy. In: Sen CK, Hanninen O, editors. Handbook of oxidants and antioxidants in exercise. Amsterdam: Elsevier, 2000:631-53
8. Kondo H, Itokẃ Y. Oxidative stress in muscular atrophy. In: Sen CK, Packer L, Hanninen O, editors. Exercise and oxygen toxicity. Amsterdam: Elsevier, 1994:319-42
9. Powers SK, Kv́zis AN, DeRuisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2005 Feb; 288(2):R337-44 (Pubitemid 40129594)
10. Powers SK, Kv́zis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 2007 Jun; 102(6):2389-97 (Pubitemid 47080773)
11. Edŕvone Acute Infarction Study Group. Effect of a novel free radical scavenger, edŕvone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15(3):222-9
12. Unno Y, Kt́yḿ M, Shimizu H. Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edŕvone therapy. Clin Drug Investig 2010;30(3):143-55
13. Lapchak PA. A critical assessment of edŕvone acute ischemic stroke efficacy trials: is edŕvone an effective neuroprotective therapy? Expert Opin Pharmacother 2010;11(10):1753-63
14. Yḿmoto Y, Kuwh́ra T, Wt́nabe K. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Redox Rep 1996;2:333-8
15. Lee BJ, Egi Y, van Leyen K, et al. Edŕvone, a free radical scavenger, protects components of the neurovascular unit ǵinst oxidative stress in vitro. Brain Res 2010 Jan 11; 1307:22-7
16. Ueno Y, Zhang N, Miyamoto N, et al. Edŕvone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model. Neuroscience 2009 Aug. 18; 162(2):317-27
17. Yḿmoto T, Yuki S, Wt́nabe T, et al. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 1997 Jul. 11; 762 (1-2): 240-2
18. Mitsubishi Tńbe Pharma Corporation. Radicut (edŕvone) [Jṕnese prescribing information]. Osḱ: Mitsubishi Tńbe Pharma Corporation, 2009
19. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 1981 Nov-Dec; 12(6):723-5 (Pubitemid 12227362)
20. Heiss WD. Experimental evidence of ischemic thresholds and functional recovery. Stroke 1992 Nov; 23(11):1668-72
21. Brunnstrom S. Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther 1966 Apr; 46(4):357-75
22. Dorman PJ, Counsell CE, Sanderrock PAG. Recently developed neuroprotective therapies for acute stroke: a qualitative systematic review of clinical trials. CNS Drugs 1996;5(6):457-74
23. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 2008 Sep; 55(3):363-89
24. O'Collins VE, Macleod MR, Donnan GA, et al. 1, 026 experimental treatments in acute stroke. Ann Neurol 2006 Mar; 59(3):467-77 (Pubitemid 43358067)
25. Shuaib A, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007 Aug. 9; 357(6):562-71 (Pubitemid 47236281)
26. Kondo H, Miura M, Kodḿ J, et al. Role of iron in oxidative stress in skeletal muscle atrophied by immobilization. Pflugers Arch 1992 Jun; 421 (2-3): 295-7
27. Kondo H, Kodḿ J, Kishibe T, et al. Oxidative stress during recovery from muscle atrophy. FEBS Lett 1993 Jul. 12; 326 (1-3): 189-91 (Pubitemid 23200274)
28. Yḿmoto Y, Yńgisẃ M, Tak NW, et al. Repeated edŕvone treatment reduces oxidative cell dḿge in rat brain induced by middle cerebral artery occlusion. Redox Rep 2009;14(6):251-8
29. Houkin K, Ueno K, Td́ M, et al. Arterial recńlization in an acute stage of cerebral infarction. Neurol Med Chir (Tokyo) 1987 Apr; 27(4):295-301